InflaRx Statistics
Total Valuation
InflaRx has a market cap or net worth of $235.67 million. The enterprise value is $192.94 million.
| Market Cap | 235.67M |
| Enterprise Value | 192.94M |
Important Dates
The last earnings date was Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
InflaRx has 147.29 million shares outstanding. The number of shares has increased by 15.84% in one year.
| Current Share Class | 147.29M |
| Shares Outstanding | 147.29M |
| Shares Change (YoY) | +15.84% |
| Shares Change (QoQ) | +2.84% |
| Owned by Insiders (%) | 2.95% |
| Owned by Institutions (%) | 7.45% |
| Float | 113.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7,033.86 |
| Forward PS | 23,027.88 |
| PB Ratio | 2.75 |
| P/TBV Ratio | 5.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5,704.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.16, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.16 |
| Quick Ratio | 3.64 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -849.90 |
Financial Efficiency
Return on equity (ROE) is -79.94% and return on invested capital (ROIC) is -48.75%.
| Return on Equity (ROE) | -79.94% |
| Return on Assets (ROA) | -39.06% |
| Return on Invested Capital (ROIC) | -48.75% |
| Return on Capital Employed (ROCE) | -113.24% |
| Weighted Average Cost of Capital (WACC) | 17.64% |
| Revenue Per Employee | $520 |
| Profits Per Employee | -$761,202 |
| Employee Count | 65 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, InflaRx has paid $14,161 in taxes.
| Income Tax | 14,161 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +104.08% in the last 52 weeks. The beta is 2.44, so InflaRx's price volatility has been higher than the market average.
| Beta (5Y) | 2.44 |
| 52-Week Price Change | +104.08% |
| 50-Day Moving Average | 1.92 |
| 200-Day Moving Average | 1.34 |
| Relative Strength Index (RSI) | 34.32 |
| Average Volume (20 Days) | 1,084,552 |
Short Selling Information
The latest short interest is 6.85 million, so 5.07% of the outstanding shares have been sold short.
| Short Interest | 6.85M |
| Short Previous Month | 6.04M |
| Short % of Shares Out | 5.07% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.27 |
Income Statement
In the last 12 months, InflaRx had revenue of $33,819 and -$49.48 million in losses. Loss per share was -$0.71.
| Revenue | 33,819 |
| Gross Profit | -8.34M |
| Operating Income | -48.96M |
| Pretax Income | -49.46M |
| Net Income | -49.48M |
| EBITDA | -48.92M |
| EBIT | -48.96M |
| Loss Per Share | -$0.71 |
Balance Sheet
The company has $45.89 million in cash and $948,954 in debt, with a net cash position of $44.94 million or $0.31 per share.
| Cash & Cash Equivalents | 45.89M |
| Total Debt | 948,954 |
| Net Cash | 44.94M |
| Net Cash Per Share | $0.31 |
| Equity (Book Value) | 42.53M |
| Book Value Per Share | 0.59 |
| Working Capital | 41.52M |
Cash Flow
In the last 12 months, operating cash flow was -$33.08 million and capital expenditures -$132,267, giving a free cash flow of -$33.45 million.
| Operating Cash Flow | -33.08M |
| Capital Expenditures | -132,267 |
| Depreciation & Amortization | 40,160 |
| Net Borrowing | -385,691 |
| Free Cash Flow | -33.45M |
| FCF Per Share | -$0.23 |
Margins
| Gross Margin | n/a |
| Operating Margin | -144,768.73% |
| Pretax Margin | -146,260.95% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
InflaRx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.84% |
| Shareholder Yield | -15.84% |
| Earnings Yield | -20.80% |
| FCF Yield | -14.06% |
Analyst Forecast
The average price target for InflaRx is $7.89, which is 393.13% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.89 |
| Price Target Difference | 393.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
InflaRx has an Altman Z-Score of -9.71 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.71 |
| Piotroski F-Score | 1 |